Heplisav ()
- Region
- 🇪🇺 EU
- Company
- Dynavax International B.V.
- Status
- Application withdrawn
- Therapeutic area
- Hepatitis B
- Application
- EMEA/H/C/002603
- ATC
- J07BC01
- Official record
- www.ema.europa.eu
Indication
Indicated for active immunisation of adults against hepatitis B virus (HBV) infection
Regulatory milestones
No milestones recorded in the last year.
Follow Heplisav
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.